Unicycive Therapeutics, Inc. (UNCY) Tops Q3 EPS by 10c

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q3 EPS of ($0.05), $0.10 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• AiRWA receives Nasdaq deficiency notice over late 10-K filing
• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79